Skip to main content
. 2021 Oct 6;22(6):1408. doi: 10.3892/etm.2021.10844

Figure 1.

Figure 1

Glioblastoma multiforme signalling pathways. PDGFRA, platelet-derived growth factor receptor A; FGFR, fibroblast growth factor receptor; INSR, insulin receptor; NF1, neurofibromin 1; MAPK, mitogen-activated protein kinase; PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; KRIT1, Krev interaction trapped; RTK, receptor tyrosin kinase; CDKN2A/B/C, cyclin-dependent kinase inhibitor 2A/B/C; CDK4/6, cyclin-dependent kinase 4/6; Rb1, retinoblastoma protein 1; MDM2/4, mouse double minute 2/4 homolog; KLLN, killin. Block arrow, inhibition; point arrow, pathway flow.